ProPhase Labs(PRPH)

Search documents
ProPhase Labs(PRPH) - 2021 Q1 - Quarterly Report
2021-05-14 21:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission file number 000-21617 ProPhase Labs, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdic ...
ProPhase Labs(PRPH) - 2021 Q1 - Earnings Call Transcript
2021-05-14 01:18
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2021 Earnings Conference Call May 13, 2021 4:30 AM ET Company Participants Ted Karkus – Chairman and Chief Executive Officer Conference Call Participants Jason Kolbert – Dawson James Robert Danaher – Private Investor Lee Alper – Hammock Investors Pat Patterson – Private Investor Operator Thank you, and good afternoon. I would like to thank you all for taking time to join us for ProPhase Labs First Quarter 2021 Financial Results Conference Call. Your host today is ProPhas ...
ProPhase Labs(PRPH) - 2020 Q4 - Earnings Call Transcript
2021-04-01 02:35
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2020 Results Conference Call March 31, 2021 4:30 PM ET Company Participants Ted Karkus - Chief Executive Officer Monica Brady - Chief Accounting Officer Conference Call Participants Operator Thank you, and good afternoon. I would like to thank you all for taking time to join us for ProPhase Labs Fourth Quarter and Full Year 2020 Financial Results Conference Call. Your host today is ProPhase Labs CEO and Chairman of the Board of Directors, Ted Karkus. A press release deta ...
ProPhase Labs(PRPH) - 2020 Q4 - Annual Report
2021-03-31 21:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 000-21617 ProPhase Labs, Inc. (Exact name of registrant as specified in its charter) | Delaware | 23-2577138 | | --- | ...
ProPhase Labs (PRPH) Investor Presentation - Slideshow
2021-03-25 16:03
ProPhase 1 NASDAQ: PRPH Investor Presentation MARCH 2021 Forward Looking Statements This presentation contains forward‐looking statements relating to our strategy and business objectives. All statements other than statements of historical facts included in this presentation may be deemed to be forward‐looking statements. You can identify forward-looking statements by words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "w ...